Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$27,000.00
Deciphering tissue microenvironment (TME) responses in brain metastasis of HER2+ breast cancer
EF 2024-25
Résumé
Breast cancer brain metastasis (BCBM) is a severe disease escalation and occurs in nearly 50% of patients with HER2+ breast cancer. Effective treatments for BCBM are urgently needed to reduce the high mortality rate of BCBM patients. Current HER2+ targeted treatments are ineffective for BCBM due to limited drug permeability through the blood-brain-barrier and drug resistance in recurring BCBM tumours. My research project uses a novel patient-derived HER2+ BCBM mouse model and offers a promising HER2+ BCBM drug treatment with significant reduction in metastatic HER2+ brain tumour burden. Alike the original patient brain metastasis tissue, HER2+ BCBM brain tumours in mice were surrounded by activated astrocytes and microglia cells, indicating crosstalk between HER2+ BCBM tumour cells and mouse brain cells. We used spatially resolved gene expression profiling of BCBM mouse brains with and without treatment to identify common and unique genes expressed in resident brain cells that surround the BCBM tumour - the microenvironment. I will use BCBM tissues to validate gene expression changes and identify the associated specific resident brain cells in which these genes are altered. My study is the first to identify brain microenvironmental gene responses in specific brain cell populations. The results will add critical new information on how resident mouse brain cells communicate with BCBM tumour cells and facilitate BCBM tumour growth and drug response. My spatial BCBM tissue study may reveal novel molecular mechanisms of communication between mouse brain and BCBM tumour cells and may reveal new targets for more effective HER2+ BCBM treatment to improve the abysmal prognosis of HER2+ BCBM patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529856
Name
Fedora Emily L
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deciphering tissue microenvironment (TME) responses in brain metastasis of HER2+ breast cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Astrocytes; Brain Metastasis; Brain Tumour Microenvironment; Breast Cancer; Her2 Inhibitor; Microglia; Spatial Transcriptomics
Abstract
Breast cancer brain metastasis (BCBM) is a severe disease escalation and occurs in nearly 50% of patients with HER2+ breast cancer. Effective treatments for BCBM are urgently needed to reduce the high mortality rate of BCBM patients. Current HER2+ targeted treatments are ineffective for BCBM due to limited drug permeability through the blood-brain-barrier and drug resistance in recurring BCBM tumours. My research project uses a novel patient-derived HER2+ BCBM mouse model and offers a promising HER2+ BCBM drug treatment with significant reduction in metastatic HER2+ brain tumour burden. Alike the original patient brain metastasis tissue, HER2+ BCBM brain tumours in mice were surrounded by activated astrocytes and microglia cells, indicating crosstalk between HER2+ BCBM tumour cells and mouse brain cells. We used spatially resolved gene expression profiling of BCBM mouse brains with and without treatment to identify common and unique genes expressed in resident brain cells that surround the BCBM tumour - the microenvironment. I will use BCBM tissues to validate gene expression changes and identify the associated specific resident brain cells in which these genes are altered. My study is the first to identify brain microenvironmental gene responses in specific brain cell populations. The results will add critical new information on how resident mouse brain cells communicate with BCBM tumour cells and facilitate BCBM tumour growth and drug response. My spatial BCBM tissue study may reveal novel molecular mechanisms of communication between mouse brain and BCBM tumour cells and may reveal new targets for more effective HER2+ BCBM treatment to improve the abysmal prognosis of HER2+ BCBM patients.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fedora, Emily L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~